ES2071608T3 - Esteres de alcanoilo de heparina de bajo peso molecular. - Google Patents

Esteres de alcanoilo de heparina de bajo peso molecular.

Info

Publication number
ES2071608T3
ES2071608T3 ES87307292T ES87307292T ES2071608T3 ES 2071608 T3 ES2071608 T3 ES 2071608T3 ES 87307292 T ES87307292 T ES 87307292T ES 87307292 T ES87307292 T ES 87307292T ES 2071608 T3 ES2071608 T3 ES 2071608T3
Authority
ES
Spain
Prior art keywords
heparin
molecular weight
low molecular
activity
weight heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87307292T
Other languages
English (en)
Inventor
Kevin Michael Foley
Charles Campbell Griffin
Eduardo Amaya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miami University
University of Miami
Original Assignee
Miami University
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/898,436 external-priority patent/US4745106A/en
Priority claimed from US06/898,130 external-priority patent/US4745105A/en
Priority claimed from US06/898,127 external-priority patent/US4745108A/en
Priority claimed from US06/898,431 external-priority patent/US4942156A/en
Priority claimed from US06/898,124 external-priority patent/US4745107A/en
Application filed by Miami University, University of Miami filed Critical Miami University
Application granted granted Critical
Publication of ES2071608T3 publication Critical patent/ES2071608T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA SERIE DE DIVERSOS DERIVADOS DE HEPARINA Y HEPARINA DE PESO MOLECULAR BAJO, QUE INCLUYEN ACETIL ESTERES DE HEPARINA Y ESTERES DERIVADOS DE HEPARINA DE BAJO PESO MOLECULAR, QUE EXHIBEN ACTIVIDAD ANTI-XA MEJORADA EN RELACION CON LA ACTIVIDAD ANTICOAGULANTE GLOBAL. TAMBIEN TRATA LA INVENCION DE DERIVADOS DE HEPARINAS NORMAL Y DE BAJO PESO MOLECULAR QUE CONTIENEN GRUPOS HIDROFOBOS Y MUESTRAN PERMEABILIDAD MEJORADA Y ADEMAS ACTIVIDAD ANTICOAGULANTE Y SOLUBILIDAD MEJORADA EN DISOLVENTES ORGANICOS.
ES87307292T 1986-08-20 1987-08-18 Esteres de alcanoilo de heparina de bajo peso molecular. Expired - Lifetime ES2071608T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US06/898,436 US4745106A (en) 1986-08-20 1986-08-20 Heparin derivatives having improved anti-Xa specificity
US06/898,130 US4745105A (en) 1986-08-20 1986-08-20 Low molecular weight heparin derivatives with improved permeability
US06/898,127 US4745108A (en) 1986-08-20 1986-08-20 Heparin derivatives having decreased anti-Xa specificity
US06/898,431 US4942156A (en) 1986-08-20 1986-08-20 Low molecular weight heparin derivatives having improved anti-Xa specificity
US06/898,124 US4745107A (en) 1986-08-20 1986-08-20 Heparin derivatives with improved permeability

Publications (1)

Publication Number Publication Date
ES2071608T3 true ES2071608T3 (es) 1995-07-01

Family

ID=27542290

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87307292T Expired - Lifetime ES2071608T3 (es) 1986-08-20 1987-08-18 Esteres de alcanoilo de heparina de bajo peso molecular.

Country Status (8)

Country Link
EP (1) EP0256880B1 (es)
JP (1) JP2643950B2 (es)
AT (1) ATE122059T1 (es)
CA (1) CA1312861C (es)
DE (1) DE3751275T2 (es)
DK (1) DK175087B1 (es)
ES (1) ES2071608T3 (es)
NO (1) NO172803C (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
US5011919A (en) * 1989-01-30 1991-04-30 Ajorca S.A. Modified heparins and obtention process
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
IT1286510B1 (it) * 1996-11-29 1998-07-15 Cooperativa Centro Ricerche Po Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono
JP4964577B2 (ja) * 2006-12-15 2012-07-04 有限会社応用糖質化学研究所 親脂質性ヘパリン修飾体、その製造方法及び毛髪成長促進剤
CN102516416A (zh) * 2011-12-28 2012-06-27 蚌埠医学院 一种肝素酯化物的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1355036A (en) * 1970-04-14 1974-06-05 Ici Ltd Articles of plastic film
JPS52111983A (en) * 1976-03-18 1977-09-20 Teijin Ltd Preparation of heparin derivatives
JPS55158055A (en) * 1979-05-25 1980-12-09 Teijin Ltd Preparation of antithrombus medical material
US4331697A (en) * 1980-09-02 1982-05-25 Teijin Limited Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
ZA829463B (en) * 1982-07-19 1983-10-26 Hepar Ind Inc Process for manufacturing low molecular weight heparins by depolymerization of normal heparin

Also Published As

Publication number Publication date
EP0256880A3 (en) 1988-12-14
JPS6366202A (ja) 1988-03-24
DE3751275T2 (de) 1995-09-07
NO873501D0 (no) 1987-08-19
ATE122059T1 (de) 1995-05-15
CA1312861C (en) 1993-01-19
DK434587A (da) 1988-02-21
NO873501L (no) 1988-02-22
NO172803C (no) 1993-09-08
DK175087B1 (da) 2004-05-24
JP2643950B2 (ja) 1997-08-25
EP0256880A2 (en) 1988-02-24
DK434587D0 (da) 1987-08-20
NO172803B (no) 1993-06-01
EP0256880B1 (en) 1995-05-03
DE3751275D1 (de) 1995-06-08

Similar Documents

Publication Publication Date Title
DE68905325T2 (de) Wellenformgenerator eines analogen Signals.
DK210388A (da) Heparinderivater med lav molekylvaegt
JPS5740503A (en) Separation of saccharides
IT1231481B (it) Derivati di furano
FR2593344B1 (fr) Source de faisceaux moleculaires
ES2071608T3 (es) Esteres de alcanoilo de heparina de bajo peso molecular.
BR7703824A (pt) Processo no qual um eter celulosico ou ester e convertido no correspondente eter ou ester de baixo peso molecular
DE3882279D1 (de) Zyklisches antikoagulierendes peptid.
AR231644A1 (es) Procedimiento de preparacion de fracciones de heparina de bajo peso molecular
ATE108801T1 (de) Antikoagulierende peptid-alkohole.
IT8767552A0 (it) Strumento per la misura del rumore di fase di segnali analogici
PT90813A (pt) Processo de preparacao de derivados da fenotiazina e de composicoes farmaceuticas que os contem
FR2334681A1 (fr) Nouveaux derives de l'acide lysergique et leur preparation
ATE13184T1 (de) Aldehydaddukte des triamterens und sie enthaltende pharmazeutische zusammensetzungen.
IT1146402B (it) Derivati di nuclei peptidici ciclici
DE69029754D1 (de) Herstellung von Thiophen-2,5-Dicarbonsäurediestern und Tetrahydrothiophen-2,5-dicarbonsäurediestern
FI902098A0 (fi) Foerfarande och anordning foer inspektion av glasskivor.
BR8806279A (pt) Sistema de processamento de dados para executar uma sequencia de instrucoes
FI870628A0 (fi) Indikator foer paovisning av klor.
IT7948980A0 (it) Derivati del 3h-indolo esenti da gruppi solfo impiegabili come coloranti basici
BE834364A (fr) Nouveaux derives acide et ester de la vinblastine
PT67538B (fr) Nouveaux derives de l'acide amino-spiro /oxa(ou thia) cicloalcane-penam/-carboxylique
DE3781543T2 (de) Unterdrueckungsschaltung von unerwuenschten zeitlichen abschnitten eines variablen spannungssignals.
BE875344A (fr) Nouveaux medicaments constituees de derives de l'acide o-aminobenzoique
FI882345A (fi) Foerfarande och anordning foer angivning av en riktning eller vinkel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 256880

Country of ref document: ES